Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

1

IJHSR. 2015; 5(5): 195-202


Biochemical Effects of Telmisartan versus Ramipril in Experimental Diabetic Nephropathy.

Snigdha Senapaty, Bhabagrahi Rath.

Abstract
Objective: The present study was undertaken to evaluate and compare the effects of ramipril which is an angiotensin converting enzyme inhibitor (ACEI) and telmisartan, an angiotensin receptor blocker (ARB) in streptozotocin (STZ) induced diabetic nephropathy in rats.
Materials and Methods: The diabetic rats were divided into four groups of six each. They were administered test drugs such as telmisartan (10mg/kg), ramipril (5mg/kg) or vehicle for 16 weeks. Blood samples were collected for the estimation of blood glucose, blood urea nitrogen, serum creatinine. Urine was collected for the measurement of protein and determination of creatinine clearance.
Results: STZ diabetic rats exhibited marked hyperglycemia, proteinuria, uremia and reduction in creatinine clearance. Telmisartan pretreatment reduced blood glucose level after 8 weeks which was not observed with ramipril. Both telmisartan and ramipril significantly altered the remaining parameters towards normal.
Conclusion: Although telmisartan is superior to ramipril with respect to blood glucose lowering effect, the renoprotective action of telmisartan appears to be similar to ramipril. Therefore telmisartan may be used as an alternative to ramipril in the treatment of hypertensive diabetic patients with nephropathy.

Key words: STZ, telmisartan, ramipril, diabetic nephropathy.



Share this Article


Advertisement
American Journal of Physiology, Biochemistry and Pharmacology

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons